A clinical trial showed evidence supporting the use of the investigational nasal spray in reducing symptom scores of social and performance anxiety. Examples of conventional anti-anxiety pharmacotherapy are serotonin reuptake inhibitors, monoamine oxidase inhibitors, benzodiazepines, and beta-blockers. These drugs may cause adverse effects, take many days to be effective, or they may not be completely effective in some patients. The novel drug works through a pheromone pathway in the central nervous system and can be used immediately preceding an anxiety-inducing situation. Researchers have commented that a further study is needed to evaluate the efficacy in a larger sample size with a longer time period. What are your thoughts about this new agent?
Image courtesy of [David Castillo Dominici]/FreeDigitalPhotos.Net